The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, J.-A.
Right arrow Articles by Kim, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, J.-A.
Right arrow Articles by Kim, B. S.
The Journal of Immunology, 2000, 165: 583-590.
Copyright © 2000 by The American Association of Immunologists

Clonal Expansion of Infiltrating T Cells in the Spinal Cords of SJL/J Mice Infected with Theiler’s Virus1

Jeong-Ah Kang, Mani Mohindru, Bong-Su Kang, Seol Hee Park2 and Byung S. Kim3

Department of Microbiology-Immunology and Institute for Neuroscience, Northwestern University Medical School, Chicago, IL 60611


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Intracerebral infection of susceptible mice with Theiler’s murine encephalomyelitis virus results in immune-mediated inflammatory demyelination in the white matter and consequent clinical symptoms. This system has been utilized as an important virus model for human multiple sclerosis. Although the potential involvement of virus-specific Th cells has been studied extensively, very little is known about the nature of T cells infiltrating the CNS during viral infection and their role in the development of demyelinating disease. In this study, the clonal nature of T cells in the spinal cord during the disease course was analyzed using size spectratyping and sequencing of the TCR ß-chain CDR3 region. These studies clearly indicate that T cells are clonally expanded in the CNS after viral infection, although the overall TCR repertoire appears to be diverse. The clonal expansion appears to be Ag-driven in that it includes Th cells specific for known viral epitopes. Interestingly, such restricted accumulation of T cells was not detectable in the infiltrates of mice with proteolipid protein peptide-induced experimental autoimmune encephalomyelitis. The initial T cell repertoire (7–9 days postinfection) seems to be more diverse than that observed in the later stage (65 days) of virally induced demyelination, despite the more restricted utilization of Vß subfamilies. These results strongly suggest continuous stimulation and clonal expansion of virus-specific T cells in the CNS of Theiler’s murine encephalomyelitis virus-infected mice during the entire course of demyelinating disease.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Theiler’s murine encephalomyelitis virus (TMEV),4 a common enteric virus in mice (1, 2), induces a chronic, inflammatory demyelinating disease in susceptible mouse strains upon intracerebral inoculation (3). The BeAn 8386 strain, which belongs to the Theiler’s original subgroup, results in a clinically undetectable early-phase disease and a severe late white-matter disease accompanied by spastic waddling gait, extensor spasms, and incontinence (3). Various immunological and genetic factors associated with this disease parallel those of human multiple sclerosis (MS), and thus this chronic progressive demyelinating disease is considered to be a relevant infectious model for MS (4, 5).

The mechanism of TMEV-induced demyelination (TMEV-IDD) is not yet clearly understood. However, recent immunological studies with susceptible SJL/J mice indicate that virus-specific CD4+ T cells with the Th1 phenotype are involved in the pathogenesis of demyelination (6, 7, 8). T cells generated during the course of demyelinating disease primarily recognize three predominant (VP1233–250, VP274–86, and VP324–37) viral epitopes (6, 7, 9). T cell populations specific for the VP1 and VP2 epitopes, infiltrating the demyelinating lesion (7) and present in the periphery (8), are primarily the Th1 type. In addition, prestimulation of T cells specific for these epitopes (but not VP3) results in acceleration of the demyelinating disease, indicating that such T cells are likely involved in the pathogenesis of demyelination (8).

The TCR repertoires involved in autoimmune diseases have extensively been investigated to understand the pathogenic mechanisms. Such information may provide a means to selectively control unwanted T cell responses via TCR-based elimination (10, 11). However, most of the autoimmune models involve repeated immunizations with either peptides or myelin Ags in potent adjuvants. The CNS-infiltrating T cell populations in these model systems range from extreme heterogeneity to some degree of oligoclonal expansions (12, 13, 14, 15). Consequently, it has been difficult to interpret whether local expansion of T cells are important for the pathogenesis in these autoimmune models. In contrast, Theiler’s virus-induced demyelination does not require repeated immunizations with adjuvants; a single intracerebral inoculation of a small number (as low as 104 PFU) of live virus consistently induces Th1-mediated demyelinating disease (16). The CTL response is considered to be the most important defense against viral infection, and consequently, the majority of studies in viral infections have focused on the CTL repertoire and function. Systemic as well as local expansion of virus-specific CD8+ cytotoxic T cells in infected mice has been observed in many different virus systems (17, 18, 19, 20, 21, 22, 23, 24). Despite the clonal expansions of CTL specific for viral epitopes after viral infection, the TCR repertoire of these T cells range from extreme heterogeneity to marked skewing in the Vß usage as well as CDR3 sequences. However, very few studies have been reported on such an expansion of virus-specific CD4+ T cells during the development of virus-induced, immune-mediated inflammatory diseases. Thus, investigation of the T cell repertoire in the CNS during the initiation and progression of demyelinating disease induced after viral infection may reveal important immune mechanisms involved in the Th1-mediated pathogenesis.

Previously, we have investigated the nature of peripheral T cell response to one of the major pathogenic Th1 epitopes (VP1233–250 region) and found it to be extremely heterogeneous in the fine minimal epitope regions and in the CDR3 sequences, although one particular Vß was preferred (25). However, conflicting results were reported regarding the predominance in the Vß usage and clonal restriction of infiltrating T cells in the demyelinating lesions (26, 27, 28). In this study, we have analyzed the diversity of the TCR ß-chain of T lymphocytes infiltrating the CNS of virus-infected mice at early and late stages, using PCR-based spectratyping and sequencing of the CDR3 region. Our results clearly demonstrate that T cells are clonally expanded in the CNS as early as 7 days after viral infection and remain in the CNS throughout the course of demyelination. However, such clonal expansion was not detectable in the CNS of mice with proteolipid protein (PLP) peptide-induced experimental autoimmune encephalomyelitis (EAE). Several of these expansions apparently represent T cells specific for known viral epitopes. The initial T cell repertoire seems to be more diverse than that observed in the later stage of viral infection, suggesting continuous Ag stimulation and specific clonal expansion in the CNS in these mice.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

Female (4–6 wk old) SJL/J mice were purchased from Charles River Laboratory (Wilmington, MA). Mice were subsequently housed in the animal care facility at Northwestern University (Chicago, IL).

Viruses

A BeAn 8386 virus stock was propagated in BHK-21 cells in DMEM supplemented with 7.5% donor calf serum.

Infection of mice with TMEV

SJL/J mice were infected intracerebrally with 2 x 106 PFU of TMEV in 30 µl of DMEM. The mice were sacrificed at various time intervals after viral infection. Spleens were removed first, and then spinal cords were dissected after extensive perfusion with cold PBS to prevent contamination with circulating lymphocytes.

Induction of EAE by immunization with PLP139–151

Mice were immunized with PLP139–151 in a modified CFA as previously described (29). Each mouse received 100 µl of CFA emulsion containing 200 µg of Mycobacterium tuberculosis H37Ra (Difco Laboratories, Detroit, MI) and 87 µg of PLP139–151 s.c. over three areas on the flank. Mice were scored according to their clinical severity as previously described (30): grade 0, no abnormality; grade 1, limp tail; grade 2, limp tail and hind limb weakness; grade 3, partial hind limb paralysis; and grade 4, complete hind limb paralysis. Initial clinical signs of disease were observed at day 13 after immunization with PLP139–151. At 18 days after immunization, mice with clinical scores between 3 and 4 were used for spectratyping of infiltrating T cells in the CNS after perfusion.

cDNA synthesis and PCR amplification

Total RNA was extracted from spleens or spinal cords using guanidine isothiocyanate (31) and cDNA synthesized by reverse transcription. The relative concentrations of cDNA were estimated based on the level of ß-actin amplification (35 cycles) by PCR. Each Vß was assessed using a sense sequence primer of the individual Vßs (Vß1, -2, -3, -4, -5, -6, -7, -10, -14, -15, -16, -17, -18, and -19) and a common antisense primer of downstream Cß as listed in Table IGo.


View this table:
[in this window]
[in a new window]
 
Table I. Oligonucleotide primer sequences

 
CDR3 size spectratyping

CDR3 size spectratyping was performed as described previously (32, 33) with minor modifications. cDNA was amplified with Vß-Cß primer pairs (Table IGo), and 1 µl of primary PCR product was then subjected to 30 cycles of a secondary amplification with the same Vß primers and a 32P-end-labeled upstream Cß primer for Vß-Cß spectratyping or 32P-end-labeled Vß primer and individual Jß primers for Vß-Jß spectratyping. Although the Jß primer sequences were identical with those published previously (33), the PCR condition was modified to reduce cross-amplification with different Jß primers (60°C for annealing in the presence of 30 mM (NH4)2SO4). Radioactive PCR products were mixed with equal volumes of denaturing buffer and heated at 94°C for 5 min. Three microliters of the samples were loaded onto a 6% acrylamide sequencing gel and were analyzed after exposure to Kodak (Rochester, NY) X-OMAT LS film.

Sequencing of PCR products

DNA isolated from individual bands on the acrylamide gel was further amplified (35 cycles) with appropriate primer pairs. The resulting PCR products were cloned into pGEM-T vector (Promega, Madison, WI) and then sequenced by the dideoxynucleotide termination method using the Sequenase kit (USB, Cleveland, OH). The CDR3 size has been defined as the number of residues minus four between the aligned cysteine (C) in the Vß element and the GXG triplet in the Jß region (34). Thus, Vß-CAS S-QERGS-SYEQYFGPG-Jß is counted as 10 amino acid residues.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Vß usage by infiltrating T cells in the spinal cord at various stages of TMEV-IDD

The relative usage of Vß subfamilies by infiltrating T cells in the CNS was initially analyzed at various time points after intracerebral inoculation with Theiler’s virus. The Vßs (Vß8, -9, -11, -12, and -13) that are deleted in the genome of the SJL/J mouse were excluded from assessment. The Vß5, also not present in SJL/J, was included as a negative control. The relative levels of Vß usage by the infiltrating T cells during the course of demyelinating disease were analyzed by agarose gel electrophoresis (Fig. 1Go). Four time points after virus infection were selected: 7 days for an early stage, 24 days for just before onset of disease, 35 days for the beginning of onset of clinical signs, and 55 days for a middle-late stage of disease. Infiltration of T cells in the spinal cords could be detected as early as 7 days after viral infection and continued at 24, 35, and 55 days postinfection. However, the Vß usage was mainly restricted to Vß1 and Vß2 at the early stage (7 days postinfection) of TMEV-IDD, and this became more diversified as the disease progressed. This diversity in Vß usage increased gradually and peaked at 35 days after viral infection. The restricted Vß usage during early infection was detectable only in the spinal cords, and all the Vßs except the negative control were similarly detected in the spleen from either virus-infected or -uninfected mice. The lack of Vß amplifications was apparent in the spinal cord of mice mock-infected with media, indicating that such an infiltration of T cells in the CNS is dependent on viral infection (Fig. 1Go). These results strongly suggest that T cells with a restricted Vß usage appearance initially in the CNS after TMEV infection before the accumulation of T cells with expanded Vß repertoire, as the pathogenesis of demyelination progresses.



View larger version (68K):
[in this window]
[in a new window]
 
FIGURE 1. Assessment of Vß family usage in the spinal cord-infiltrating T cells at various stages of TMEV-IDD. RNA was prepared from the spinal cord at days 7, 24, 35, and 55 postinfection, from mock-infected spinal cord (C), and from the spleen (Spl). cDNA was synthesizied from each RNA preparation and then amplified by PCR using individual Vß (Vß1, -2, -3, -4, -5, -6, -7, -10, -14, -15, -16, -17, -18, and -19) sense primer and a common Cß antisense downstream primer. Vß5 deleted in the genome of SJL/J was used as a negative control. PCR amplification products were analyzed by agarose gel electrophoresis.

 
Analysis of CDR3 sequences of infiltrating T cells at 9 and 65 days postinfection

Because infiltrating T cells at the early stage of viral infection utilize primarily Vß1 and Vß2 (Fig. 1Go), T cells with these Vßs were further investigated. The level of CDR3 diversity among infiltrating T cells expressing Vß1 or Vß2 was initially analyzed by sequencing the Vß-Cß cDNA clones that were derived from RT-PCR of spinal cords at an early (day 9) and a late stage (day 65). Table IIGo shows the CDR3 sequences of TCR ß-chain bearing Vß1 and Vß2 subfamilies. Some CDR3 sequences were repeatedly found, e.g., 5 of the 25 Vß1-Cß clones displayed QERGS-SYEQYF(Jß2.6), and 11 of 22 Vß2-Cß clones exhibited AGD-YAEQFF(Jß2.1). These results strongly suggest the clonal expansion of such Vß1+ and Vß2+ T cell populations in the spinal cords of virus-infected mice. However, the relative frequencies of the CDR3 sequences found at early and late stages appear to be somewhat different. For example, the Vß1-QDTE-YEQYF(Jß2.6) sequence (4 of 12 clones) and the Vß2-AGGGG/A-YEQYF(Jß2.6) sequence (7 of 12 clones) were the most frequent at day 65, whereas these were either minor (1 of 25) or much less frequent (4 of 22) at day 9 postinfection, respectively. These results indicate that some T cell clones from the initial infiltration are further expanded, whereas certain T cell clones contracted as the demyelination progressed. Nevertheless, most of the predominant CDR3 sequences detected at the early stage of infection were maintained during the course of viral infection, in that the same sequences are also found at a late stage (65 days postinfection).


View this table:
[in this window]
[in a new window]
 
Table II. Deduced CDR3 amino acid sequences of Vß1 or Vß2 TCR amplified from spinal cord T cells after infection of SJL/J mice with TMEV1

 
Spectratyping of CDR3 sizes of the selective Vß-Cß and Vß-Jß combinations

The size distribution of the CDR3 regions of selective Vß-Cß and Vß-Jß combinations of T cells from the spleens and spinal cords of virus-infected mice were compared (Fig. 2GoA). The CDR3 spectratypes of the spleens from uninfected mice showed a Gaussian distribution, indicating a typical heterogeneous distribution of CDR3 sizes among the T cells in the periphery. The pattern of CDR3 size distribution of splenic T cells from infected mice (Fig. 2GoA) was identical with that of uninfected mice (Fig. 2GoB), suggesting that the presence of virus-induced T cells in the periphery does not alter the pattern of normal CDR3 size distribution. In contrast, the CDR3 spectrum of the T cells from the pooled spinal cords of infected mice was markedly skewed. Vß-Cß as well as Vß-Jß combinations displayed one or two predominant bands, suggesting the expansion of specific T cell clones. All major bands from spinal cords at 9 days postinfection, except the 10-aa size band detected in the Vß2-Jß2.6 combination, were apparently maintained throughout the course of demyelinating disease, as readily seen in the pooled spinal cords at 65 days postinfection. However, several bands reflecting newly expanded T cell clones (e.g., 9 aa in Vß2-Cß, 8 aa in Vß1-Jß2.6, and 9 aa in Vß2-Jß2.6) were detected only in the spinal cords at the late stage (65 days) of viral infection. The initial Vß1-Jß1.1 and Vß1-Jß2.1 spectratyping yielded one prominent band each (Fig. 2GoA). However, assessment of the CDR3 sequences revealed that the Jß1.1 had been cross-amplified by Jß1.3 primer and that the Jß2.1 had been cross-amplified by Jß2.6 primer in these particular combinations (data not shown). The PCR condition was further optimized by addition of (NH4)2SO4 to prevent the cross-amplification in subsequent studies (see Materials and Methods for details).



View larger version (58K):
[in this window]
[in a new window]
 
FIGURE 2. CDR3 size spectratyping of spinal cord T cells at an early and late stage of TMEV-IDD. The primary amplified PCR products of spinal cord T cells were further characterized by carrying out a run-off reaction using a radiolabeled upstream Cß primer for Vß-Cß combination or a radiolabeled Vß1 or Vß2 for Vß-Jß combination. The final amplified PCR products were mixed with equal volume of denaturing buffer and then were loaded onto a 6% sequencing gel after boiling at 94°C for 5 min. A, CDR3 size spectratyping of pooled spinal cords from 9 and 65 days postinfected SJL/J mice. B, CDR3 size spectratyping of T cells from a single spinal cord at 9 days postinfection (not included in pooled spinal cord in A) using 12 combinations of Vß1-Jß or Vß2-Jß. spl, spleen; sc, spinal cord.

 
The above TCR ß-chain CDR3 spectratypes of infiltrating T cells from the pooled spinal cords were compared with that from a single mouse cord to assess the variation in individual mice. The CDR3 spectratypes in all the combinations of Vß1-Jßs and Vß2-Jßs of a mouse excluded from the pool were examined at 9 days postinfection (Fig. 2GoB). The spectratypes of the splenic T cells from this virus-infected mouse again showed the Gaussian distribution in each combination, representing a typical heterogeneous CDR3 pattern of bulk T cells. The faint bands in the Vß1-Jß1.5 and Vß2-Jß1.5 spectratypes may reflect the rare use of Jß1.5 in SJL/J mice (35). Perhaps this is because of the polymorphism in this mouse strain at the very beginning of this Jß (36). In contrast to the heterogeneous pattern of splenic T cells, only a few prominent bands were observed in the combinations of Vß1-Jßs and Vß2-Jßs of the infiltrating T cells, suggesting a marked expansion of restricted T cell clones. The pattern was very similar to that seen with the pooled spinal cords (Fig. 2GoA), although some differences in the band pattern were noted. These differences may represent minor variations in the repertoire development of infiltrating T cells in response to viral infection among different individual mice. Nevertheless, the predominant CDR3 pattern is similar among individual mice, suggesting an Ag-driven T cell expansion in the CNS of virus-infected mice.

Analyses of CDR3 sequences of the major spectratype bands

To analyze the degree of CDR3 heterogeneity in the individual major bands of Vß-Cß or Vß-Jß combinations, each band was excised, cloned, and subsequently sequenced (Table IIIGo). Every band displayed highly homogeneous nucleotide sequences for each, suggesting that the individual bands in the spectratyping indeed represent clonal expansions of specific T cells. Because the spectratype pattern of pooled spinal cords at 9 days postinfection was similar to that at 65 days (Fig. 2Go), the representative major bands of the Vß-Cß amplifications were analyzed initially (Table IIIGo). The CDR3 sequence data clearly indicate that the majority of T cell clones initially expanded at early stage of viral infection remained predominant throughout the course of demyelinating disease. In addition, it appears that a restricted number of T cell clones are predominant for these Vß subfamilies, in that each prominent CDR3 size of the Vß-Cß combinations contains only one or two identical CDR3 sequences (Table IIIGo). The band patterns and sequence data suggest that such T cell expansions become somewhat more restricted within cells expressing the same Vßs at a later period. The most frequent CDR3 sequences corresponded well to the sequences of cDNA clones generated directly from the spinal cords of virus-infected mice (Table IIGo). These data clearly indicate that viral infection induces and maintains identical predominant T cell clones in individual mice during the entire course of demyelinating disease.


View this table:
[in this window]
[in a new window]
 
Table III. Deduced CDR3 amino acid sequences of spectratype-derived TCR from spinal cord T cells at early and late stage of TMEV-IDD1

 
To further analyze the extent of clonal expansion of T cells and the level of TCR diversity, the spectratypes of the Vß and individual Jß combinations of infiltrating T cells from pooled spinal cords and a single cord were assessed (Table IIIGo). The majority of individual bands represent a single clone of T cells, and the others also contain very restricted numbers of clones based on the identical or restricted sequences for each band. Again, the frequency of sequences from the Vß-Jß spectratype bands matched well with that of Vß-Cß bands or sequences of Vß-Cß cDNA clones derived directly from spinal cords. When the sequences of Vß-Jß spectratype bands were compared between the pooled spinal cords and a single cord, the major predominant bands of the single cord were identical with the sequences of the pool. However, minor individual variations in the sequences (Table IIIGo) as well as in the spectratyping pattern (Fig. 2Go) were noted, suggesting that different T cell clones may also be expanded in individual mice in response to the same virus.

Presence of CDR3 sequences specific for viral epitopes in the spectratype bands

We previously generated many different Th cell clones and hybridomas reactive to the viral capsid epitopes, and some of the TCR CDR3 regions were analyzed (Ref. 25 and unpublished data). Because VP1233–250- and VP274–86-specific T cell clones could be derived from the CNS infiltrates, such T cells are most likely represented in the inflammatory lesions (7). To verify whether the clonally expanded T cells in the CNS identified by spectratyping include virus-specific Th cells, the CDR3 sequences of virus-specific T cell hybridomas and clones with known epitope specificity were compared with those found in the spectratype bands. The CDR3 sequences identical with that of T cell clones/hybridomas specific for VP274–86 and VP324–37 were found in certain spectratype bands. These include Vß2-ATD-Jß1.1 specific for VP274–86 (Fig. 2GoA and Table IIIGo) and Vß16-RGRN-Jß1.1 specific for VP324–37 (data not shown). Therefore, it is most likely that these clonally expanded T cell populations include CD4+ Th cells specific for viral epitopes. However, comparison of the CDR3 sequences of the spectratype bands with the epitope specificity is difficult due to the extensive diversity of CDR3 sequences and the limited sequence data for functional T cells directly derived from the CNS infiltrates.

Comparison of the CDR3 spectratypes to that of infiltrating T cells from mice with EAE

It has previously been reported that T cell clones recognizing the encephalitogenic PLP epitope (PLP139–151) in SJL/J mice with EAE, an autoimmune model of human MS, use diverse TCR repertoire (12, 14). To compare the magnitude of infiltrating T cell repertoire involved in TMEV-induced demyelination to that involved in EAE, similar analyses of CDR3 in PLP139–151-induced EAE were performed (Fig. 3Go and Table IVGo). The CDR3 spectratype patterns of spinal cord T cells from SJL/J mice with EAE were extremely diverse, similar to that observed in the spleen. Furthermore, the sequence data of two representative spectratyping bands unequivocally support the exceptional TCR heterogeneity of infiltrating T cells in EAE (Table IVGo). No two cDNA clones showed identical sequences except one duplicate CDR3 sequence in the Vß1-Jß2.6 combination (Vß1-QVRPGR-Jß2.6). This extreme diversity of TCR repertoire in EAE sharply contrasts to that seen in TMEV-IDD (Table IIIGo). Therefore, infiltrating autoreactive T cells involved in the induction of EAE are not likely to represent clonally expanded T cells in the CNS. This may represent the differences in the nature of T cell activation in these model systems, i.e., extensive peripheral stimulation of autoantigen-reactive T cells in the presence of potent adjuvant vs selective clonal expansion of virus-induced T cells in the CNS due to the tissue-confined chronic viral persistence.



View larger version (46K):
[in this window]
[in a new window]
 
FIGURE 3. CDR3 size spectratyping of spinal cord T cells from PLP139–151-induced EAE. EAE was induced by immunization with PLP139–151 in modified CFA. CDR3 size spectratyping of spinal cord T cells from clinically affected mice at 18 days postimmunization were performed as described in Fig. 2Go. spl, spleen; sc, spinal cord.

 

View this table:
[in this window]
[in a new window]
 
Table IV. Deduced CDR3 amino acid sequences of spectratype-derived TCR from spinal cord T cells of PLP-induced EAE

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The identification of clonal restriction in the TCR repertoire of infiltrating T cells has been of keen interest to immunologists (10, 37, 38, 39). Such a restriction in the TCRs may provide a powerful tool to control T cells involved in autoimmune responses by specifically eliminating the TCR-bearing T cell populations (10, 11). Several research groups initially reported that autoantigen-reactive T cell clones derived from MS patients appear to be restricted in the use of certain Vß subfamily genes (40, 41, 42). However, this approach to eliminate specific Vß-bearing T cells met limited success in the experimental models because of the relatively high heterogeneity of T cell repertoire specific for a given autoantigen or peptide (13, 43). These autoimmune models of MS require repeated immunizations with either peptides or whole proteins of myelin Ags emulsified in potent adjuvants. Often such immunizations do not reflect the true immune responses to native autoantigens during the development of autoimmune diseases. In addition, compelling yet circumstantial evidences strongly suggest the involvement of infectious agents (most likely viral) in the initiation of MS that may induce autoimmunity to myelin components. Theiler’s virus infection fulfills these criteria of an infectious model for MS, including the late development of autoimmunity to myelin Ags (44). Thus, this TMEV-IDD system may reveal more pertinent T cell responses involved in the development of inflammatory demyelinating diseases.

In this study, we have analyzed the TCR Vß repertoire at the clonal level by spectratyping and sequencing the CDR3 region of infiltrating T cells after TMEV infection in susceptible SJL/J mice. This approach has been used successfully to identify oligoclonal T cell expansion without isolating T cells during viral infections and/or immune-mediated disease states (15, 20, 21, 22). Dramatic clonal expansion has recently been observed after lymphocytic choriomeningitis virus infection (21, 22). However, such drastic clonal expansion has been less clear in the host infected with other viruses or undergoing immune-mediated diseases (17, 18, 19, 20). We demonstrate here that clonally restricted T cells accumulate in the CNS as early as 7 days after viral infection and that this expansion is maintained throughout the course of virally induced demyelinating disease (Fig. 2Go and Table IIIGo). This is markedly different from the nature of T cell populations involved in PLP139–151-induced EAE, where no such clonal expansion is apparent in the CNS during the autoantigen-induced demyelinating disease (Fig. 3Go and Table IVGo). The lack of clonal restriction of T cells found in EAE does not appear to reflect the differences in the level of T cell infiltration in that comparable numbers of T cells have been found in these two different systems (Ref. 28 and data not shown). However, although it is unlikely, the possibility of similar clonal restriction among T cells bearing Vßs other than those tested in this study cannot be excluded. In addition, it is conceivable that Vß bias becomes more pronounced when whole proteins relying on naturally processed T cell determinants rather than on peptides are used, as shown in myelin basic protein-induced EAE in the rat system (43, 45). Nevertheless, the accumulation of clonally restricted T cells in the CNS of TMEV-infected mice is much more pronounced and most likely is a result of the fact that the majority of infiltrating cells in the demyelinating lesions are void of nonspecific T cell populations found in the periphery. Therefore, this clonal accumulation in the CNS after viral infection strongly suggests that such T cells have been locally stimulated and expanded in response to chronic viral persistence because no detectable skewing patterns are found in the peripheral T cells of virus-infected mice.

Using the DA strain of TMEV, Rodriguez (26) reported previously that no TCR Vß subfamily is preferentially used by infiltrating T cells in the spinal cords of resistant (B10.K) or susceptible (B10.Q) mice during the early or late course of viral infection. In addition, no such preferential use of Vßs by infiltrating T cells was observed even in highly susceptible SJL mice at a late (day 45) or very late (day 238) stage (26). These studies were based on the relative RT-PCR amplifications of Vß-Cß combinations and were interpreted as the lack of specific clonal expansion in the infiltration. In contrast to the above studies, our results clearly indicate that preferential use of certain Vß subfamilies can be detected at an early stage of viral infection (days 7–9) in susceptible SJL mice, although the Vß usage is expanded as the infection progresses (Fig. 1Go). The CDR3 size distribution pattern of infiltrating T cells in the CNS of SJL/J mice has also been investigated by another group (27), and this group showed highly restricted CDR3 sizes in many Vß-Jß combinations of infiltrating T cells after infection with TMEV DA strain. However, sequencing results of two representative bands displayed extremely heterogeneous CDR3 sequences, rendering these results very difficult to interpret. In sharp contrast to the above studies with the DA strain, our sequencing results (Table IIIGo) of the predominant bands clearly indicate that skewing in the CDR3 size bands indeed represents clonal expansion of T cells in the CNS infiltration. The discrepancies between our current study and the previous studies with TMEV may reflect the differences in the virus strains used (BeAn vs. DA) and/or the dose of virus used for infection. Our observation of significantly more heterogeneous T cell responses after infection with a high dose of virus or a low-pathogenic variant virus strongly supports these possibilities (data not shown). Because a viral dose resulting in clinical demyelinating disease in virtually 100% mice was used in our study, such clonal expansion of T cells must be involved in the pathogenesis of virus-induced, immune-mediated demyelinating disease.

Because some of the CDR3 sequences match with those of virus-specific Th cells selected in vitro, these clonal expansions are most likely to be driven in response to viral infection. This is consistent with the predominant clonal expansion of CD8+ CTL population, in which virus-specific expansion of T cell population is apparent (21, 22). Similarly restricted CDR3 size band distributions and sequences have also been observed in these studies. However, it is not yet clear whether all of the expanded T cell clones represent virus-specific T cells or if they include autoreactive T cells generated because of "epitope spreading" as a result of immune-mediated tissue damage by virus-specific T cells (44). In addition, the contribution of CD8+ T cells in the predominant spectratyping pattern is also not clear, although presence of low levels of CD8+ T cells and CTL function toward TMEV are found in susceptible SJL/J mice (46). It is most likely that the T cell responses to viral infection may include both CD4+ Th as well as CD8+ T cells specific for viral Ags and/or autoantigens generated after viral infection. Nevertheless, our experimental data clearly demonstrate that T cells are clonally expanded in the infiltrating lesions of demyelination throughout the course of disease, although the TCR repertoire appears to be broad. We are currently further analyzing the major T cell population expanded during viral infection to correlate with the pathogenicity and Ag specificity involved in the T cell expansion. These studies may provide useful information on the nature of T cell populations that are involved in the pathogenesis of demyelinating disease.


    Acknowledgments
 
We thank Drs. Carol Vanderlugt and Stephen Miller for their assistance in induction of EAE with PLP139–151 peptide.


    Footnotes
 
1 This work was supported by Research Grants NS 23349, NS 28752, and NS 33008 from the U.S. Public Health Service and by Grant RG 3126-A-4 from the National Multiple Sclerosis Society. Back

2 Current address: Department of Anatomical Pathology, Korea University Medical Center, Seoul, Korea. Back

3 Address correspondence and reprint request to Dr. Byung S. Kim, Department of Microbiology-Immunology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611. Back

4 Abbreviations used in this paper: TMEV, Theiler’s murine encephalomyelitis virus; TMEV-IDD, TMEV-induced demyelination; MS, multiple sclerosis; PLP, proteolipid protein; EAE, experimental autoimmune encephalomyelitis. Back

Received for publication February 14, 2000. Accepted for publication April 19, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Theiler, M.. 1934. Spontaneous encephalomyelitis of mice: a new virus disease. Science 80:122.[Free Full Text]
  2. Friedmann, A., Y. Lorch. 1985. Theiler’s virus infection: a model for multiple sclerosis. Prog. Med. Virol. 31:43.[Medline]
  3. Lipton, H. L., M. C. Dal Canto. 1976. Chronic neurologic disease in Theiler’s virus infection of SJL/J mice. J. Neurol. Sci. 30:201.[Medline]
  4. Dal Canto, M. C., B. S. Kim, S. D. Miller, R. W. Melvold. 1996. Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple sclerosis. Methods 10:453.[Medline]
  5. Kim, B. S., J. P. Palna. 1999. Immune mechanisms of Theiler’s virus-induced demyelination. Exp. Mol. Med. 31:115.[Medline]
  6. Gerety, S. J., W. J. Karpus, A. R. Cubbon, R. G. Goswami, M. K. Rundell, J. D. Peterson, S. D. Miller. 1994. Class II-restricted T cell responses in Theiler’s murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J. Immunol. 152:908.[Abstract]
  7. Yauch, R. L., B. S. Kim. 1994. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler’s virus is located within VP1(233–244). J. Immunol. 153:4508.[Abstract]
  8. Yauch, R. Y., J. P. Palma, H. Yahikozawa, C.-S. Koh, B. S. Kim. 1998. Role of individual T cell epitopes of Theiler’s virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J. Virol. 72:6169.[Abstract/Free Full Text]
  9. Yauch, R. L., K. Kerekes, K. Saujani, B. S. Kim. 1995. Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler’s virus in demyelination-susceptible SJL/J mice. J. Virol. 69:7315.[Abstract]
  10. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, L. Steinman. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.[Medline]
  11. Urban, J. L., V. Kumar, D. H. Kono, C. Gomez, S. J. Horvath, J. Clayton, D. G. Ando, E. E. Sercarz, L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577.[Medline]
  12. Kuchroo, V. K., M. Collins, A. al-Sabbagh, R. A. Sobel, M. J. Whitters, S. S. Zamvil, M. E. Dorf, D. A. Hafler, J. G. Seidman, H. L. Weiner, et al 1994. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR Vß 8.2 transgenic mice. J. Exp. Med. 179:1659.[Abstract/Free Full Text]
  13. Bell, R. B., J. W. Lindsey, R. A. Sobel, S. Hodgkinson, L. Steinman. 1993. Diverse T cell receptor Vß gene usage in the central nervous system in experimental allergic encephalomyelitis. J. Immunol. 150:4085.[Abstract]
  14. Kuchroo, V. K., R. A. Sobel, J. C. Laning, C. A. Martin, E. Greenfield, M. E. Dorf, M. B. Lees. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein: fine specificity and T cell receptor Vß usage. J. Immunol. 148:3776.[Abstract]
  15. Kim, G., N. Tanuma, T. Kojima, K. Kohyama, Y. Suzuki, Y. Kawazoe, Y. Matsumoto. 1998. CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis. J. Immunol. 160:509.[Abstract/Free Full Text]
  16. Kim, B. S., R. L. Yauch, Y. Y. Bahk, J. A. Kang, M. C. Dal Canto, C. K. Hall. 1998. A spontaneous low-pathogenic variant of Theiler’s virus contains an amino acid substitution within the predominant VP1233–250 T-cell epitope. J. Virol. 72:1020.[Abstract/Free Full Text]
  17. Cole, G. A., T. L. Hogg, D. L. Woodland. 1994. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767.[Abstract/Free Full Text]
  18. Chen, Z. W., L. Shen, J. D. Regan, Z. Kou, S. H. Ghim, N. L. Letvin. 1996. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 156:1469.[Abstract]
  19. Silins, S. L., S. M. Cross, S. L. Elliott, S. J. Pye, J. M. Burrows, D. J. Moss, I. S. Misko. 1997. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection. Int. Immunol. 9:1745.[Abstract/Free Full Text]
  20. Naumov, Y. N., K. T. Hogan, E. N. Naumova, J. T. Pagel, J. Gorski. 1998. A class I MHC-restricted recall response to a viral peptide is highly polyclonal despite stringent CDR3 selection: implications for establishing memory T cell repertoires in "real-world" conditions. J. Immunol. 160:2842.[Abstract/Free Full Text]
  21. Sourdive, D. J., K. Murali-Krishna, J. D. Altman, A. J. Zajac, J. K. Whitmire, C. Pannetier, P. Kourilsky, B. Evavold, A. Sette, R. Ahmed. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71.[Abstract/Free Full Text]
  22. Lin, M. Y., R. M. Welsh. 1998. Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J. Exp. Med. 188:1993.[Abstract/Free Full Text]
  23. Pewe, L., S. Perlman. 1999. Immune response to the immunodominant epitope of mouse hepatitis virus is polyclonal, but functionally monospecific in C57BL/6 mice. Virology 255:106.[Medline]
  24. Marten, N. W., S. A. Stohlman, W. Smith-Begolka, S. D. Miller, E. Dimacali, Q. Yao, S. Stohl, J. Goverman, C. C. Bergmann. 1999. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system. J. Immunol. 162:3905.[Abstract/Free Full Text]
  25. Kim, B. S., Y. Y. Bahk, H. K. Kang, R. L. Yauch, J. A. Kang, M. J. Park, N. M. Ponzio. 1999. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230–250) of Theiler’s virus: Vß restriction correlates with T cell recognition of the C-terminal residue. J. Immunol. 162:7049.[Abstract/Free Full Text]
  26. Rodriguez, M., N. Prayoonwiwat, P. Zhou, C. David. 1993. Expression of T cell receptor Vß transcripts in central nervous system of mice susceptible and resistant to Theiler’s virus-induced demyelination. J. Neuroimmunol. 47:95.[Medline]
  27. Musette, P., J. F. Bureau, G. Gachelin, P. Kourilsky, M. Brahic. 1995. T lymphocyte repertoire in Theiler’s virus encephalomyelitis: the nonspecific infiltration of the central nervous system of infected SJL/J mice is associated with a selective local T cell expansion. Eur. J. Immunol. 25:1589.[Medline]
  28. Pope, J. G., W. J. Karpus, C. Vanderlugt, S. D. Miller. 1996. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler’s virus-induced demyelinating disease: evidence for a CD4+ T cell-mediated pathology. J. Immunol. 156:4050.[Abstract]
  29. McRae, B. L., M. K. Kennedy, L. J. Tan, M. C. Dal Canto, K. S. Picha, S. D. Miller. 1992. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:229.[Medline]
  30. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.[Abstract/Free Full Text]
  31. Chomczynski, P., N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.[Medline]
  32. Cochet, M., C. Pannetier, A. Regnault, S. Darche, C. Leclerc, P. Kourilsky. 1992. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639.[Medline]
  33. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor ß chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90:4319.[Abstract/Free Full Text]
  34. Rock, E. P., P. R. Sibbald, M. M. Davis, Y. H. Chien. 1994. CDR3 length in antigen-specific immune receptors. J. Exp. Med. 179:323.[Abstract/Free Full Text]
  35. Candeias, S., C. Waltzinger, C. Benoist, D. Mathis. 1991. The Vß 17+ T cell repertoire: skewed Jß usage after thymic selection; dissimilar CDR3s in CD4+ versus CD8+ cells. J. Exp. Med. 174:989.[Abstract/Free Full Text]
  36. Bahk, Y. Y., C. A. Kappel, G. Rasmussen, B. S. Kim. 1997. Association between susceptibility to Theiler’s virus-induced demyelination and T-cell receptor Jß-Cß1 polymorphism rather than Vß deletion. J. Virol. 71:4181.[Abstract]
  37. Offner, H., G. Hashim, A. A. Vandenbark. 1987. Response of rat encephalitogenic T lymphocyte lines to synthetic peptides of myelin basic protein. J. Neurosci. Res. 17:344.[Medline]
  38. Heber-Katz, E.. 1990. The autoimmune T cell receptor: epitopes, idiotopes, and malatopes. Clin. Immunol. Immunopathol. 55:1.[Medline]
  39. Hafler, D. A., M. G. Saadeh, V. K. Kuchroo, E. Milford, L. Steinman. 1996. TCR usage in human and experimental demyelinating disease. Immunol. Today 17:152.[Medline]
  40. Acha-Orbea, H., L. Steinman, H. O. McDevitt. 1989. T cell receptors in autoimmune disease as targets for immune intervention. Genome 31:656.[Medline]
  41. Oksenberg, J. R., M. A. Panzara, A. B. Begovich, D. Mitchell, H. A. Erlich, R. S. Murray, R. Shimonkevitz, M. Sherritt, J. Rothbard, C. C. Bernard, et al 1993. Selection for T-cell receptor Vß-Dß-Jß gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68.[Medline]
  42. Offner, H., A. A. Vandenbark. 1999. T cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP-specific clones. Int. Rev. Immunol. 18:9.[Medline]
  43. Sun, D., J. Le, C. Coleclough. 1993. Diverse T cell receptor ß chain usage by rat encephalitogenic T cells reactive to residues 68–88 of myelin basic protein. Eur. J. Immunol. 23:494.[Medline]
  44. Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, B. S. Kim. 1997. Persistent infection with Theiler’s virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133.[Medline]
  45. Gold, D. P., H. Offner, D. Sun, S. Wiley, A. A. Vandenbark, D. B. Wilson. 1991. Analysis of T cell receptor ß chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J. Exp. Med. 174:1467.[Abstract/Free Full Text]
  46. Dethlefs, S., M. Brahic, E. L. Larsson-Sciard. 1997. An early, abundant cytotoxic T-lymphocyte response against Theiler’s virus is critical for preventing viral persistence. J. Virol. 71:8875.[Abstract]



This article has been cited by other articles:


Home page
J. Virol.Home page
Y. V. Mendez-Fernandez, M. J. Hansen, M. Rodriguez, and L. R. Pease
Anatomical and Cellular Requirements for the Activation and Migration of Virus-Specific CD8+ T Cells to the Brain during Theiler's Virus Infection
J. Virol., March 1, 2005; 79(5): 3063 - 3070.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. J. Simmons, M. Koneru, M. Mohindru, R. Thomas, S. Cutro, P. Singh, R. H. DeKruyff, G. Inghirami, A. J. Coyle, B. S. Kim, et al.
Tim-3+ T-bet+ Tumor-Specific Th1 Cells Colocalize with and Inhibit Development and Growth of Murine Neoplasms
J. Immunol., February 1, 2005; 174(3): 1405 - 1415.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. Boudinot, D. Bernard, S. Boubekeur, M.-I. Thoulouze, M. Bremont, and A. Benmansour
The glycoprotein of a fish rhabdovirus profiles the virus-specific T-cell repertoire in rainbow trout
J. Gen. Virol., October 1, 2004; 85(10): 3099 - 3108.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Kang, O. Liesenfeld, J. S. Remington, J. Claflin, X. Wang, and Y. Suzuki
TCR V{beta}8+ T Cells Prevent Development of Toxoplasmic Encephalitis in BALB/c Mice Genetically Resistant to the Disease
J. Immunol., April 15, 2003; 170(8): 4254 - 4259.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Schluter, T. Meyer, L.-Y. Kwok, M. Montesinos-Rongen, S. Lutjen, A. Strack, M. L. Schmitz, and M. Deckert
Phenotype and Regulation of Persistent Intracerebral T Cells in Murine Toxoplasma Encephalitis
J. Immunol., July 1, 2002; 169(1): 315 - 322.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Kook, A. M. Risitano, W. Zeng, M. Wlodarski, C. Lottemann, R. Nakamura, J. Barrett, N. S. Young, and J. P. Maciejewski
Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens
Blood, May 15, 2002; 99(10): 3668 - 3675.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, J.-A.
Right arrow Articles by Kim, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, J.-A.
Right arrow Articles by Kim, B. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS